A prospective randomized comparative study of the difference in cytopathologic diagnosis between EUS-FNA with or without suction in pancreatic and peripancreatic masses
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0000878
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Patients with pancreatic or peri-pancreatic solid masses who need EUS-FNA for diagnosis
Exclusion Criteria
1) Age < 19
2) Ongoing gastrointestinal bleeding
3) Coagulation disorder (platelet < 50,000/mm3 and/or prothrombin time international normalized ratio(PT INR) > 1.5)
4) In use of Thienopyridine (e.g. clopidogrel)
5) Refusal to provide informed consent
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic accuracy
- Secondary Outcome Measures
Name Time Method Sample quality (cellularity, number of cells per slide, adequacy of specimen, blood contamination)